Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's Witness with locally advanced pancreatic cancer: Case report and approach to avoid transfusion

American Surgeon

Volumn 72, Issue 5, 2006, Pages 435-437

  Magner, David ^a   Ouellette, James R ^a   Lee, Joseph R ^a   Colquhoun, Steven ^a   Lo, Simon ^a   Nissen, Nicholas N ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERROUS SULFATE; FOLIC ACID; GEMCITABINE; HEMOGLOBIN;

ADJUVANT THERAPY; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPH NODE DISSECTION; PANCREAS CANCER; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; PHLEBOTOMY; POSTOPERATIVE PERIOD; SUPERIOR MESENTERIC ARTERY; ADENOCARCINOMA; HEMODILUTION; JEHOVAH'S WITNESS; PANCREAS TUMOR; RADIOGRAPHY;

ADENOCARCINOMA; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HEMODILUTION; HUMANS; JEHOVAH'S WITNESSES; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745413283     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Crist DW, Sitzman JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358-65.
2. Lin P-W, Lin Y-J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999;86:603-7.
3. Chiada M, Furuse A, Kotsua Y, et al. Open heart surgery in Jehovah's Witness patients. Cardiovasc Surg 1996;4:311-4.
4. Moskowiz DM, Perelman SI, Cousineau KM, et al. Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium. Can J Anesth 2002;49:402-8.
5. Jabbour N, Gagandeep S, Mateo R, et al. Live donor liver transplant without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg 2004;240:350-7.
6. Muromoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's Witnesses. Br Med J 2001;322:37-9.
7. Muromoto O. Recent developments in medical care of Jehovah's Witnesses. West J Med 1999;170:297-301.
8. Jessup J, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128:559-63.
9. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335-9.
10. Ghaneh P, Neoptolemos J. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy for pancreatic cancer. Surg Oncol Clin N Am 2004;13:567-87.
11. Sarac TP, Clifford C, Waters J, et al. Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. J Vasc Surg 2003;37:453-5.
12. Grande AM, Rinaldi M, D'Armini AM, et al. Lung transplantation in a Jehovah's Witness. Case report in a twinning procedure. J Cardiovasc Surg (Torino) 2003;44:131-4.
13. Braga M, Gianotti L, Gentilini O, et al. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. Hepatogastroenterology 1997;44:685-90.
14. Kajikawa M, Nonami T, Kurokawa T, et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery 1994;115:727-34.
15. Kosmadakis N, Messaris E, Maris A, et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 2003;237:417-21.